Oriola operates in the Finnish and Swedish health and wellbeing markets

Oriola serves the health and wellbeing market with modern and customer-focused products and services, and connects all actors within the field, from pharmaceutical companies to pharmacies and consumers.

Interim Report Q3 2025

Oriola will publish its Interim Report January-September 2025 on Thursday 30 October 2025 at around 8.30 a.m. Welcome to join our results presentation as a live webcast at 10 a.m. on the same day.

Pareto Securities' Healthcare Conference

Oriola attended Pareto Securities' Healthcare Conference in Stockholm on 16 September 2025 with CEO Katarina Gabrielson as a speaker.

Oriola's science-based climate targets

Oriola’s ambitious science-based climate targets approved by the SBTi. This approval makes Oriola one of the companies globally recognised by the SBTi as having an approved science-based net-zero target under the SBTi Net-Zero Standard.

Annual Report 2024

Growth through strategy implementation. Find out more about Oriola's year 2024.